𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mutational analysis of the class I β-tubulin gene in human breast cancer

✍ Scribed by Seiichi Hasegawa; Yasuo Miyoshi; Chiyomi Egawa; Makoto Ishitobi; Yasuhiro Tamaki; Morito Monden; Shinzaburo Noguchi

Publisher
John Wiley and Sons
Year
2002
Tongue
French
Weight
244 KB
Volume
101
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Non-small cell lung cancers have a high incidence of somatic mutations of the beta-tubulin (class I) gene, suggesting involvement in the acquisition of resistance to taxanes, which exert their effects through binding to beta-tubulin. Since taxanes are often used in the treatment of breast cancer, we carried out a mutational analysis of the class I beta-tubulin (GenBank accession AF070600) gene in breast cancer. We paid special attention to the primer design so as not to amplify the pseudogenes. We identified 1 somatic mutation, codon 306 [Arg (CGC) to Cys (TGC)], and 2 genetic polymorphisms, codon 217 [Leu (CTG) to Leu (CTA)] and (C to T) at 57 bases downstream from exon 4. Our results suggest that acquisition of resistance to taxanes is unlikely to be explained by somatic mutations of the class I beta-tubulin gene in most breast cancers. In addition, the overestimation of the incidence of somatic mutations of the class I beta-tubulin gene due to the pseudogenes is discussed.

📜 SIMILAR VOLUMES

Mutational analysis of the p73 Gene in h
Mutational analysis of the p73 Gene in human breast cancers
✍ Tomotane Shishikura; Shingo Ichimiya; Toshinori Ozaki; Yoshinori Nimura; Hajime 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 163 KB 👁 2 views

In primary breast cancer, mutations of the p53 tumor suppressor gene lead to loss of growth-suppressive properties and poor outcome. Recently, a p53-related gene, termed p73, has been cloned and its gene product possesses a function similar to p53. p73 has been mapped at chromosome 1p36.3, a region

Lack of β-tubulin gene mutations in earl
Lack of β-tubulin gene mutations in early stage lung cancer
✍ Maija R.J. Kohonen-Corish; Han Qin; Joseph J. Daniel; Wendy A. Cooper; Laurent R 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 55 KB

## Dear Sir, Lung cancer causes the most cancer-related deaths in western countries and its treatment remains a challenge. Encouraging results have been obtained recently with new chemotherapeutic agents such as paclitaxel in non-small-cell lung cancer. A striking association, however, has been re

Mutational analysis of the TrkA gene in
Mutational analysis of the TrkA gene in prostate cancer
✍ George, Daniel J.; Suzuki, Hiroyoshi; Bova, G. Steven; Isaacs, John T. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 629 KB

## Background: Trka, the high affinity, tyrosine kinase receptor for nerve growth factor (ngf) has been implicated as an oncogene in several neoplasms. in prostate cancer, inhibitors of the ngf/trka signal pathway results in tumor growth inhibition. in contrast, inhibition of this trk pathway in th

Mutational analysis of the p16 gene in h
Mutational analysis of the p16 gene in human neuroblastomas
✍ Javier S. Castresana; Lourdes Gómez; Purificación García-Miguel; Antonio Queizán 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 2 views

Neuroblastoma is one of the most frequent tumors in infancy. We analyzed 26 neuroblastomas, two ganglioneuromas, and a neuroblastoma metastasis for mutations and homozygous deletions of the p16 (or MTS1 or CDKN2) gene by means of the polymerase chain reaction (PCR) in combination with the single-str